GB9217475D0 - Nauroprotective use cck antagonists - Google Patents

Nauroprotective use cck antagonists

Info

Publication number
GB9217475D0
GB9217475D0 GB929217475A GB9217475A GB9217475D0 GB 9217475 D0 GB9217475 D0 GB 9217475D0 GB 929217475 A GB929217475 A GB 929217475A GB 9217475 A GB9217475 A GB 9217475A GB 9217475 D0 GB9217475 D0 GB 9217475D0
Authority
GB
United Kingdom
Prior art keywords
nauroprotective
cck antagonists
use cck
antagonists
nauroprotective use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB929217475A
Other versions
GB2259013A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Publication of GB9217475D0 publication Critical patent/GB9217475D0/en
Publication of GB2259013A publication Critical patent/GB2259013A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB9217475A 1991-08-19 1992-08-17 Neuroprotective use of CCK antagonists Withdrawn GB2259013A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919117852A GB9117852D0 (en) 1991-08-19 1991-08-19 Therapeutic agents

Publications (2)

Publication Number Publication Date
GB9217475D0 true GB9217475D0 (en) 1992-09-30
GB2259013A GB2259013A (en) 1993-03-03

Family

ID=10700185

Family Applications (2)

Application Number Title Priority Date Filing Date
GB919117852A Pending GB9117852D0 (en) 1991-08-19 1991-08-19 Therapeutic agents
GB9217475A Withdrawn GB2259013A (en) 1991-08-19 1992-08-17 Neuroprotective use of CCK antagonists

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB919117852A Pending GB9117852D0 (en) 1991-08-19 1991-08-19 Therapeutic agents

Country Status (1)

Country Link
GB (2) GB9117852D0 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554644A (en) * 1994-06-08 1996-09-10 Warner-Lambert Company Tachykinin (NK2) antagonists
US7160880B1 (en) 1999-05-14 2007-01-09 Cenes Limited Short-acting benzodiazepines
US9193730B2 (en) 2006-07-10 2015-11-24 Paion Uk Limited Short-acting benzodiazepine salts and their polymorphic forms
MX2009011923A (en) 2007-05-10 2009-11-18 Amr Technology Inc Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin.
EP2450039A1 (en) 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
WO2012075456A1 (en) 2010-12-02 2012-06-07 Constellation Pharmaceuticals Bromodomain inhibitors and uses thereof
AR084070A1 (en) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc BROMODOMINIUM INHIBITORS AND USES OF THE SAME
EP2705039B1 (en) 2011-05-04 2017-07-26 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
EP2721031B1 (en) 2011-06-17 2016-01-20 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
WO2013184878A1 (en) 2012-06-06 2013-12-12 Constellation Pharmaceuticals, Inc. Benzo [b] isoxazoloazepine bromodomain inhibitors and uses thereof
TWI602820B (en) 2012-06-06 2017-10-21 星宿藥物公司 Bromodomain inhibitors and uses thereof
AR094963A1 (en) 2013-03-04 2015-09-09 Ono Pharmaceutical Co EXCELLENT OXIDATION REACTION IN THE CONVERSION INDEX
ES2725928T3 (en) 2014-06-20 2019-09-30 Constellation Pharmaceuticals Inc Crystal forms of 2 - ((4S) -6- (4-chlorophenyl) -1-methyl-4H-benzo [c] isoxazolo [4,5-e] azepin-4-yl) acetamide
GB201506448D0 (en) 2015-04-16 2015-06-03 Univ Durham An antimicrobial compound
US10881667B2 (en) 2018-10-30 2021-01-05 City University Of Hong Kong Method and composition for treating epilepsy
EP4334298A1 (en) 2021-06-14 2024-03-13 Scorpion Therapeutics, Inc. Urea derivatives which can be used to treat cancer

Also Published As

Publication number Publication date
GB9117852D0 (en) 1991-10-09
GB2259013A (en) 1993-03-03

Similar Documents

Publication Publication Date Title
HU9301603D0 (en) Angiotensine 11 antagonists
HU913074D0 (en) Fibrinogenic receptor antagonists
ZA92600B (en) Lhrh antagonists
PH31071A (en) Substituted pyrridopyrimidines useful antgiotensinII antagonists.
DE69211247D1 (en) Ellipsometer
BG95816A (en) New sulphonylcarbamides
GB9217475D0 (en) Nauroprotective use cck antagonists
EP0574530A4 (en) Endothelin antagonists
GB2246992B (en) Gangway
ZA911111B (en) Leukotriene antagonists
HU9503191D0 (en) Adhesion-receptor antagonists
GB9127041D0 (en) New use
GB9114397D0 (en) Multi-purpose hitchlock
GB2261684B (en) Construction component
NZ241872A (en) Substituted oxaspirononane paf antagonists
GB9108499D0 (en) Bowls
ZA922586B (en) Cholecystokinin antagonists
GB9101503D0 (en) New use
ZA913604B (en) Heterocyclic-nmda antagonists
GB9106467D0 (en) Tendons
GB9100721D0 (en) Endothelin antagonists
ZA921465B (en) Anti-thrombin polypeptides
IE900033L (en) Beta-adrenergic antagonists
GB9121661D0 (en) New use
GB9104834D0 (en) New use

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)